Barclay Alec (CIK 0001734339)

Latest company ownership

Role: Chief Operations Officer
Shares held
181,944.88
Last filed at
Apr 11, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Apr 8, 2022 Apr 11, 2022 T2 Biosystems, Inc. Chief Operations Officer Buy 85.0 +12,951 7.66% $6.5K
Mar 14, 2022 Mar 30, 2022 T2 Biosystems, Inc. Chief Operations Officer Sell 47.5 -11,428 -6.33% $4.2K
Feb 24, 2021 Feb 28, 2022 T2 Biosystems, Inc. Chief Operations Officer Sell 46.3 -88,878 -35.89% $39.9K
Feb 21, 2021 Feb 23, 2022 T2 Biosystems, Inc. Chief Operations Officer Sell 47.5 -5,275 -6.25% $2.5K
Mar 17, 2021 Mar 18, 2021 T2 Biosystems, Inc. Chief Operations Officer Sell 28.8 -12,494 -14.38% $23.2K
Feb 21, 2021 Feb 23, 2021 T2 Biosystems, Inc. Chief Operations Officer Sell 28.8 -7,280 -10.04% $15K
Feb 21, 2020 Feb 25, 2020 T2 Biosystems, Inc. SVP, Operations Sell 30.0 -5,808 -11.15% $4.8K
Sep 11, 2019 Sep 13, 2019 T2 Biosystems, Inc. SVP, Operations Sell 32.5 -4,210 -9.09% $12.3K
Sep 11, 2018 Sep 13, 2018 T2 Biosystems, Inc. SVP, Operations Sell 26.3 -3,522 -9.48% $22.9K
Jul 20, 2018 Jul 24, 2018 T2 Biosystems, Inc. Officer Sell 22.5 -7,824 -22.37% $52.6K
Jun 6, 2018 Jun 8, 2018 T2 Biosystems, Inc. SVP, Operations Sell 91.3 +9,175 534.05% $37.6K